LABETALOL HYDROCHLORIDE IN DEXTROSE Drug Patent Profile
✉ Email this page to a colleague
When do Labetalol Hydrochloride In Dextrose patents expire, and what generic alternatives are available?
Labetalol Hydrochloride In Dextrose is a drug marketed by Hikma and is included in one NDA.
The generic ingredient in LABETALOL HYDROCHLORIDE IN DEXTROSE is labetalol hydrochloride. There are fourteen drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the labetalol hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Labetalol Hydrochloride In Dextrose
A generic version of LABETALOL HYDROCHLORIDE IN DEXTROSE was approved as labetalol hydrochloride by HERITAGE PHARMA on August 3rd, 1998.
Summary for LABETALOL HYDROCHLORIDE IN DEXTROSE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Clinical Trials: | 67 |
Formulation / Manufacturing: | see details |
DailyMed Link: | LABETALOL HYDROCHLORIDE IN DEXTROSE at DailyMed |
Recent Clinical Trials for LABETALOL HYDROCHLORIDE IN DEXTROSE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Loma Linda University | N/A |
Zagazig University | Phase 2 |
Nebraska Methodist Health System | Phase 4 |
Pharmacology for LABETALOL HYDROCHLORIDE IN DEXTROSE
Drug Class | beta-Adrenergic Blocker |
Mechanism of Action | Adrenergic beta-Antagonists |
Anatomical Therapeutic Chemical (ATC) Classes for LABETALOL HYDROCHLORIDE IN DEXTROSE
US Patents and Regulatory Information for LABETALOL HYDROCHLORIDE IN DEXTROSE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hikma | LABETALOL HYDROCHLORIDE IN DEXTROSE | labetalol hydrochloride | SOLUTION;INTRAVENOUS | 213330-001 | Nov 9, 2020 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |